This inventor holds 1 USPTO granted patent. Top assignee: Johns Hopkins University. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Andreas Oberbach
Introduction
Andreas Oberbach is a notable inventor based in Leipzig, Germany. He has made significant strides in the field of medical technology, particularly in minimally invasive procedures aimed at weight loss. His work focuses on innovative methods that enhance patient outcomes and improve existing techniques.
Latest Patents
Oberbach holds a patent for an endoscopic gastric mucosal ablation/resection/exclusion (A/R/E) method. This invention is designed to endoscopically ablate, resect, or exclude the mucosa of the gastric fundus and body. The method aims to induce cellular death in ghrelin-producing hormone cells, providing a more permanent solution compared to current methods that only offer transient ischemia. This innovative approach not only reduces ghrelin levels but also induces scarring in the gastric fundus, leading to reduced accommodation of excess food and promoting early satiety. He has 1 patent to his name.
Career Highlights
Oberbach is affiliated with Johns Hopkins University, where he contributes to research and development in medical technologies. His work is characterized by a commitment to advancing minimally invasive techniques that can significantly impact patient care and treatment options.
Collaborations
He has collaborated with esteemed colleagues such as Anthony Nicolas Kalloo and Mouen A Khashab, further enhancing the scope and impact of his research.
Conclusion
Andreas Oberbach's innovative contributions to the field of medical technology exemplify the potential of minimally invasive procedures in weight loss treatments. His patent for the endoscopic gastric mucosal A/R/E method represents a significant advancement in the field, promising better outcomes for patients.